Octanediamide

CAS: 149647-78-9
Molecular Formula: C14H20N2O3
Molecular Weight: 264.32
Product description:A kind of new molecular targeted anti-tumor drugs, through inhibiting histone acetyl enzyme (histone deacetylase, HDAC) and make the stagnation of the cell cycle and/or apoptosis. It is the first approved by the FDA for the treatment of the two body still progress, resistance or recurrence after treatment has obvious skin against skin t-cell lymphoma (CTCL) HDAC inhibitors.A histone deacetylase (HDAC) inhibitors. Can through the induction of cell differentiation, block the cell cycle, inducing cell regulation and play a role. Treatment is aggravating, continuous and recurrence or invalid skin after treatment with two kinds of systemic drugs t-cell lymphoma (CTCL, a kind of non-hodgkin's lymphoma). CTCL is a kind of influence white blood cell types of T cell carcinoma of the skin.